H. Dugan

发表

Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets

Henry A. Utset, Christopher T. Stamper, Nicholas W. Asby, 2021, Immunity.

Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses

Karlynn E. Neu, Linda Yu-Ling Lan, Christopher T. Stamper, 2020, Immunity.

Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses

Karlynn E. Neu, Linda Yu-Ling Lan, Henry A. Utset, 2020, Immunity.

Teach ‘em young: Influenza vaccines induce broadly neutralizing antibodies in children

P. Wilson, H. Dugan, 2022, Cell reports. Medicine.

Semaphorin 7A modulates cytokine‐induced memory‐like responses by human natural killer cells

R. K. Reeves, Olivier Lucar, S. Jost, 2019, European journal of immunology.

Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1

M. Altfeld, M. Carrington, G. Alter, 2016, Nature Immunology.

Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity

Christopher T. Stamper, J. Hubbell, M. Swartz, 2022, Science advances.

An Efficient Method to Generate Monoclonal Antibodies from Human B Cells.

Karlynn E. Neu, P. Wilson, Jenna J. Guthmiller, 2018, Methods in molecular biology.

Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID‐19 convalescent plasma clinical trial

Henry A. Utset, J. Alverdy, C. Bethel, 2020, medRxiv.

Proinflammatory IgG Fc structures in patients with severe COVID-19

Shenmin Zhang, J. Andrews, J. Taubenberger, 2020, Nature Immunology.

Symptomatic SARS-CoV-2 infections display specific IgG Fc structures.

Shenmin Zhang, J. Andrews, J. Taubenberger, 2020, medRxiv : the preprint server for health sciences.

Broadly neutralizing antibodies target a haemagglutinin anchor epitope

Henry A. Utset, Christopher T. Stamper, J. Bloom, 2021, Nature.

Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike

Henry A. Utset, Christopher T. Stamper, Y. Kawaoka, 2021, mBio.

Improved integration of single-cell transcriptome and surface protein expression by LinQ-View

Patrick C. Wilson, Florian Krammer, Lei Li, 2021, Cell reports methods.

Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01

M. Altfeld, S. Jost, C. Simoneau, 2015, PloS one.

A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like Receptors

M. Altfeld, Tim Wang, S. Jost, 2021, Frontiers in Immunology.

Aging and influenza vaccine-induced immunity.

P. Wilson, Carole J Henry, H. Dugan, 2019, Cellular immunology.

SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike

Henry A. Utset, Christopher T. Stamper, C. Nelson, 2021, mBio.

Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2

Henry A. Utset, Christopher T. Stamper, Nicholas W. Asby, 2020, Research square.

SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike

Henry A. Utset, Christopher T. Stamper, C. Nelson, 2020, bioRxiv.

Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike

Henry A. Utset, Christopher T. Stamper, Y. Kawaoka, 2021, Research square.

Human antigen-specific memory natural killer cell responses develop against HIV-1 and influenza virus and are dependent on MHC-E restriction

M. Altfeld, P. Goepfert, A. Grundhoff, 2020, bioRxiv.

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

Christopher T. Stamper, D. Bernstein, P. Wilson, 2019, The Lancet. Infectious diseases.

SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II

Christopher T. Stamper, J. Hubbell, M. Swartz, 2021, medRxiv.

Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans

Karlynn E. Neu, Henry A. Utset, Christopher T. Stamper, 2020, Science Translational Medicine.

Evolution of antibody immunity following Omicron BA.1 breakthrough infection

D. Burton, Tyler N. Starr, L. Walker, 2023, Nature communications.

Evolution of antibody immunity following Omicron BA.1 breakthrough infection

D. Burton, Tyler N. Starr, L. Walker, 2022, bioRxiv.

First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes

Henry A. Utset, Christopher T. Stamper, P. Wilson, 2021, Science Translational Medicine.

A public broadly neutralizing antibody class targets a membrane-proximal anchor epitope of influenza virus hemagglutinin

Henry A. Utset, Christopher T. Stamper, J. Bloom, 2021, bioRxiv.

Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages

L. Walker, D. Sheward, B. Murrell, 2023, Nature communications.

Proinflammatory IgG Fc structures in patients with severe COVID-19

Shenmin Zhang, J. Andrews, J. Taubenberger, 2020, Nature Immunology.

Librator, a platform for optimized sequence editing, design, and expression of influenza virus proteins

Christopher T. Stamper, P. Wilson, Nai-Ying Zheng, 2021, bioRxiv.

Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies

Christopher T. Stamper, Nai-Ying Zheng, K. Michalska, 2024, iScience.